Pharmacy Repackaging Systems Market Research Report, by Product Type (Solid Medication Packaging System, Liquid Medication Packaging System), Dosage Type (Unit Dose, Multiple Unit), End User (Retail Pharmacy, Hospital Pharmacy) & ndash; Global Forecast Till 2030

Pharmacy Repackaging Systems Market Scenario

The Pharmacy Repackaging Systems Market is anticipated to reach USD 2.05 Billion by 2030 at 7.10% CAGR during the forecast period 2022-2030.The pharmacy repackaging systems market is projected to grow significantly over the forecast period.

The pharmaceutical repackaging is act of transferring the pharmaceutical dosage from primary container (manufacturer) and introducing it into another container which is usually smaller  in size.

The repackaging systems are rapidly growing owing to the factors such as significant reduction in cost and errors, advance drug inventory management, and rise in awareness of automated systems in developed economies are driving growth of market globally. Further, the increasing cases of erroneous deaths because of the improper administration of the medicines and drugs is expected to drive the growth of the market.

Moreover, the absence of awareness about the potential advantages these computerized systems can offer in a few regional markets has been a critical inhibitor. Besides, major companies in the market are involved in new product launches to strengthen their position in the market.

Segmentation

The pharmacy repackaging systems market is segmented on the basis of product type, dosage type, and end user.

The market, by product type is categorised into solid medication packaging systems, liquid medication packaging systems, bottle filling/ pill counting automation systems, and others. The solid medication packaging systems is further divided into blister card packaging systems, and pouch packaging automation systems. The blister card packaging systems is further divided into multi dose blister card packaging systems, single dose blister card packaging systems, and heat sealers. The liquid medication packaging systems is further divided into oral liquid filling system, vial filling system, and syringe filling system.

Based on dosage type, the market of pharmacy repackaging systems is segmented into unit dose packaging and multiple unit packaging.

On the basis of end user, the market is segmented into retail/community pharmacy, hospital pharmacy, Long-term Care (LTC) pharmacies, and others. The hospital pharmacy is further segmented into Outpatient Pharmacy, and Inpatient Pharmacy.

On the basis of region, the pharmacy repackaging systems market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The pharmacy repackaging systems market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Pharmacy Repackaging Systems Market Share (%), by Region, 2017

Sources: Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services, National Institutes of Health

It is projected that the Americas dominated the pharmacy repackaging systems market owing to the growth of the market in the North American region. This is largely attributed to the factors such as rising number of outpatient visits that encourages pharmacists and hospitals to incorporate automated systems in order to improve their prescription-handling capacity.

Europe is expected to hold the second largest share in the market of pharmacy repackaging systems owing to growing healthcare infrastructure. Additionally, various initiatives by public and private organizations is anticipated to boost the growth of the market.

Asia-Pacific was projected to be the fastest growing region for the pharmacy repackaging systems market. This owes to the technological advancements resulting in the development of cost-effective pharmacy repackaging systems leading to high acceptance rate for the devices in the Asia-Pacific region.

The Middle East and Africa holds the least share in the pharmacy repackaging systems market due to the presence of economically diverse countries, and less initiatives taken by the government.

Pharmacy repackaging systems Market, by Product type

• Solid Medication Packaging Systems




• Blister Card Packaging Systems




• Multi Dose Blister Card Packaging Systems


• Single Dose Blister Card Packaging Systems


• Heat Sealers




• Pouch Packaging Automation Systems




• Liquid Medication Packaging Systems




• Oral Liquid Filling System


• Vial Filling System


• Syringe Filling System




• Bottle Filling/ Pill Counting Automation Systems


• Others

Pharmacy repackaging systems Market, by Dosage type

• Unit Dose Packaging


• Multiple Unit Packaging

Pharmacy repackaging systems Market, by End User

• Retail/Community Pharmacy


• Hospital Pharmacy




• Outpatient Pharmacy


• Inpatient Pharmacy




• Long-term Care (LTC) Pharmacies


• Others

Pharmacy repackaging systems Market, by Region

• Americas




• North America




• US


• Canada




• Latin America




• Europe




• Western Europe




• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe




• Eastern Europe




• Asia-Pacific




• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific




• The Middle East & Africa




• Middle East


• Africa

Pharmacy repackaging systems Market, Key Players

• Arxium


• Becton Dickinson & Company (Carefusion Corporation)


• Kirby Lester


• Medical Packaging Inc


• Omnicell, Inc


• Parata Systems


• Pearson Medical Technologies


• Proficient Rx


• Swisslog Holding Ltd


• Takazono Corp


• Tcgrx


• Yuyama Co., Ltd

Intended Audience

• Medical device companies


• Pharmaceutical companies


• Government institutions


• Research and Development (R&D) companies


• Medical research laboratories

Frequently Asked Questions (FAQ) :